KERYX BIOPHARMACEUTICALS INC Increase (Decrease) in Inventories
KERYX BIOPHARMACEUTICALS INC reported Increase (Decrease) in Inventories of $36.72 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2018-11-08
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for the quarter ending 2018-09-30 was $12.21M, a 70.41% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for the quarter ending 2018-06-30 was $15.81M, a 181.70% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for the quarter ending 2018-03-31 was $8.71M.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for the quarter ending 2017-12-31 was $4.16M, a 2633.55% increase year-over-year.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for fiscal 2017 was $16.00M, a 595.65% increase from fiscal 2016.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for fiscal 2016 was $2.30M, a 92.12% decline from fiscal 2015.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for fiscal 2015 was $29.19M, a 275.61% increase from fiscal 2014.
- KERYX BIOPHARMACEUTICALS INC increase (decrease) in inventories for fiscal 2014 was $7.77M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2018-09-30 | $12.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $28.01M derived: sum of 2 quarters · filed 2018-11-08 | $36.72M 10-Q · filed 2018-11-08 | $40.88M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | $15.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $24.52M 10-Q · filed 2018-08-09 | $28.67M derived: sum of 3 quarters · filed 2018-08-09 | $35.83M derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-03-31 | $8.71M 10-Q · filed 2018-05-10 | $12.87M derived: sum of 2 quarters · filed 2018-05-10 | $20.03M derived: sum of 3 quarters · filed 2018-11-08 | $25.64M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $11.32M derived: sum of 2 quarters · filed 2018-11-08 | $16.93M derived: sum of 3 quarters · filed 2018-11-08 | $16.00M 10-K · filed 2018-02-21 |
| 2017-09-30 | $7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $12.77M derived: sum of 2 quarters · filed 2018-11-08 | $11.85M 10-Q · filed 2018-11-08 | $12.00M derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $4.68M 10-Q · filed 2018-08-09 | $4.83M derived: sum of 3 quarters · filed 2018-08-09 | $3.17M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$928.00K 10-Q · filed 2018-05-10 | -$776.00K derived: sum of 2 quarters · filed 2018-05-10 | -$2.44M derived: sum of 3 quarters · filed 2018-05-10 | $1.74M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.51M derived: sum of 2 quarters · filed 2017-11-07 | $2.67M derived: sum of 3 quarters · filed 2017-11-07 | $2.30M 10-K · filed 2017-03-01 |
| 2016-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.52M derived: sum of 2 quarters · filed 2017-11-07 | $2.15M 10-Q · filed 2017-11-07 | $3.82M derived: sum of 4 quarters · filed 2017-11-07 |
| 2016-06-30 | $4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $3.81M 10-Q · filed 2017-07-27 | $5.48M derived: sum of 3 quarters · filed 2017-07-27 | $6.99M derived: sum of 4 quarters · filed 2017-07-27 |
| 2016-03-31 | -$371.00K 10-Q · filed 2017-05-04 | $1.30M derived: sum of 2 quarters · filed 2017-05-04 | $2.81M derived: sum of 3 quarters · filed 2017-05-04 | $9.50M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.18M derived: sum of 2 quarters · filed 2017-03-01 | $9.87M derived: sum of 3 quarters · filed 2017-03-01 | $29.19M 10-K · filed 2017-03-01 |
| 2015-09-30 | $1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $8.20M derived: sum of 2 quarters · filed 2016-11-09 | $27.52M 10-Q · filed 2016-11-09 | $34.38M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $6.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $26.01M 10-Q · filed 2016-08-05 | $32.87M derived: sum of 3 quarters · filed 2017-03-01 | |
| 2015-03-31 | $19.32M 10-Q · filed 2016-04-28 | $26.18M derived: sum of 2 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $6.86M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $7.77M 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $912.00K 10-Q · filed 2015-10-29 |